Treating uveitis with phaco

Article

Phacoemulsification can increase visual acuity in uveitis patients, concluded a study published in the January issue of the British Journal of Ophthalmology.

Phacoemulsification can increase visual acuity in uveitis patients, concluded a study published in the January issue of the British Journal of Ophthalmology.

Susan Lightman of Moorfields Eye Hospital, London, UK and colleagues conducted a retrospective medical record review of uveitis patients (n=101) undergoing phacoemulsification and intraocular lens (IOL) implantation.

Visual acuity was significantly improved (≥2 lines) for 64.4% and 71.3% of patients at first postop and final follow-up visits, respectively. Over six years’ follow-up, slightly more than half of patients doubled their visual angle; this was more prevalent among eyes with preop lesions on either the retina or optic nerve. At three months, postoperative uveitis was most likely to develop in female patients or those with significant perioperative posterior synechiae. Patients with postop uveitis were at increased risk of developing macular oedema.

Thus the team concluded that, although phacoemulsification tends to increase visual acuity in uveitis patients, those patients with macular or optic nerve lesions are more likely to lose visual acuity.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.